Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ANI Acquires Generic Drugs from Teva | Contract Pharma

What are you searching for?

Sign in
Breaking News

ANI Acquires Generic Drugs from Teva

Gains 31 marketed products for $12.5 million in cash

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ANI Pharmaceuticals, Inc. has acquired 31 marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash, as well as a percentage of future profits on product sales. The acquisition includes 20 solid-oral immediate release products, four extended release products, and seven liquid products. ANI is transferring these products to its manufacturing facilities and anticipates product launches beginning in 4Q14. All of the products are approved by the FDA as abbreviated new drug applications (ANDAs). The market for these products is estimated to be valued at $860 million according to IMS Health. 

Arthur S. Przybyl, president and chief executive officer of ANI Pharmaceuticals, said, “This acquisition is a significant opportunity for ANI to expand our generic product portfolio beyond our current seven marketed products. When launched, these products will strengthen our business by growing our revenue base and leveraging our manufacturing capabilities. We are excited that this transaction extends the ANI-Teva relationship beyond the existing generic testosterone gel partnership.”
 
Robert W. Schrepfer, vice president of new business development, said, “This transaction demonstrates ANI’s commitment to diversify our marketed product portfolio and supplement our internal product development efforts through a business development plan that includes partnerships, acquisitions and in-licensing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics